Such production will be carried out with the Russian-Nicaraguan joint company Mechnikov, the institute in charge of producing the Convacel vaccine against Covid-19, according to the bulletin Informe Pastrán, which quotes a recent interview of López to Canal Parlamentario (Parliamentary Channel).

The head of the Inss also referred to the elaboration here of the vaccine against the Human Papilloma Virus to prevent cervix cancer.

Regarding dengue, the CEO noted that there is already a prototype of the injectable, which is in clinical trials in the initial stage in Russia.

According to Lopez, this will allow the manufacturing of the vaccine against the four serotypes, in about three years.

In addition, they are betting on the haemophilus vaccine to combat pneumonia, meningitis, pericarditis, blood, bone, and joint infections.

The president of the INSS highlighted the annual production of vaccines against the influenza virus, which placed Nicaragua among the 18 countries in the world that manufacture vaccines against the referred disease and has prepared itself to face any other epidemic.

jrr/jav/mem/ybv